Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keating

Showing results (771-780 of 964) with videos related to

Pageof 97
Sort By:
Journal of Neurovirology|August 28, 2013
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain statusSuyang Li, Ying Wu, Sheila M Keating, et al.
Cancer|September 15, 1985
Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapyA R Zander, K A Dicke, M Keating, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Clinical Orthopaedics and Related Research|December 1, 1995
Flat-on-flat, nonconstrained, compression molded polyethylene total knee replacementM A Ritter, R Worland, J Saliski, et al.
Leukemia|August 2, 2001
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromeS Verstovsek, H Kantarjian, E Estey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected WomenAnjali Sharma, Yifei Ma, Rebecca Scherzer, et al.
Molecular Immunology|March 1, 1995
Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chainsK M Keating, D B Segal, S J Craig, et al.
Cancer Treatment Reports|May 1, 1981
Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemiaA R Zander, L Vellekoop, G Spitzer, et al.
BJR Open|November 12, 2020
Differences in degree of lesion enhancement on CEM between ILC and IDCThiemo Ja van Nijnatten, Maxine S Jochelson, Katja Pinker, et al.
The New England Journal of Medicine|December 17, 1987
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromesS Vadhan-Raj, M Keating, A LeMaistre, et al.
Pageof 97

Showing results (771-780 of 964) with videos related to

Sort By:
Pageof 97
Journal of Neurovirology|August 28, 2013
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain statusSuyang Li, Ying Wu, Sheila M Keating, et al.
Cancer|September 15, 1985
Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapyA R Zander, K A Dicke, M Keating, et al.
Leukemia|March 1, 1997
Decitabine studies in chronic and acute myelogenous leukemiaH M Kantarjian, S M O'Brien, E Estey, et al.
Clinical Orthopaedics and Related Research|December 1, 1995
Flat-on-flat, nonconstrained, compression molded polyethylene total knee replacementM A Ritter, R Worland, J Saliski, et al.
Leukemia|August 2, 2001
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromeS Verstovsek, H Kantarjian, E Estey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected WomenAnjali Sharma, Yifei Ma, Rebecca Scherzer, et al.
Molecular Immunology|March 1, 1995
Enhanced immunoreactivity and preferential heterodimer formation of reassociated Fel d I recombinant chainsK M Keating, D B Segal, S J Craig, et al.
Cancer Treatment Reports|May 1, 1981
Combination of high-dose cyclophosphamide, BCNU, and VP-16-213 followed by autologous marrow rescue in the treatment of relapsed leukemiaA R Zander, L Vellekoop, G Spitzer, et al.
BJR Open|November 12, 2020
Differences in degree of lesion enhancement on CEM between ILC and IDCThiemo Ja van Nijnatten, Maxine S Jochelson, Katja Pinker, et al.
The New England Journal of Medicine|December 17, 1987
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromesS Vadhan-Raj, M Keating, A LeMaistre, et al.
Pageof 97